Acute promyelocytic leukemia

Peter H. Wiernik*, Robert E. Gallagher, Martin S. Tallman

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations


Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation inducing agents, and because of our advanced understanding of the molecular biology of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.

Original languageEnglish (US)
Title of host publicationNeoplastic Diseases of the Blood
PublisherSpringer New York
Number of pages51
ISBN (Electronic)9781461437642
ISBN (Print)1461437636, 9781461437635
StatePublished - Nov 1 2013


  • All-trans retinoic acid
  • Arsenic trioxide
  • Pseudotumor cerebri
  • Translocation 15;17

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Acute promyelocytic leukemia'. Together they form a unique fingerprint.

Cite this